. HPLC Chromatograms of the purified peptides. 
III.
Supporting Table:   Table S1 . Mass spectrometry data for the peptides. were synthesized following the previously published protocol. 2 Briefly, unnatural amino acids, (R)-2-(7'octenyl)alanine (R 8 , Aldrich) and (S)-2-(4'pentenyl)-alanine (S 5 , Aldrich), were introduced via standard Fmoc SPPS method. Olefin metathesis reaction was performed twice on solid support using 6 mM solution of Grubbs' first-generation catalyst (Aldrich) in 1,2-dichloroethane (Aldrich). Unnatural aromatic amino acid containing peptides were synthesized using Fmoc amino acid derivatives, Fmoc β-(3-pyridyl)-Ala-OH (Aldrich) and N α -Fmoc-N ε -acridinyl Lysine. 3 HPLC chromatograms and MALDI-MS data are shown in Fig. S1 and Table   S1 .
Circular Dichroism. CD spectra of 20 µM of stapled peptide solutions in 10 mM sodium phosphate (pH 7.4) were measured as same as previously described. 4 Briefly, CD spectra were measured with a Chirascan plus circular dichroism detector (Applied Photophysics, Leatherhead, U.K.). Peptide solutions were transferred to a precision cell (Quartz Suprasil, 0.05 cm, Hellma analytics), and CD spectra were recorded from 190 to 260 nm with a bandwidth of 1.0 nm. The measurement was performed in triplicate, and the measured values were averaged.
The graph of mean residue molar ellipticity was converted to the graph of Delta Epsilon, and analysis was performed using CDNN, version 2.1, authored by G. Böhm at the Institute for and RNA was removed using RNase H (NEB). qRT-PCR was performed on a Rotor-Gene (Bio-Rad, USA) with gene-specific primers (Table S2) and Rotor-Gene SYBR ® Green PCR kit (Qiagen). The relative amounts of mRNA were calculated by using the comparative C T method 6 . GAPDH was used for normalization. For animal skin samples, RNA was transcribed using TaqMan® MicroRNA Reverse Transcription kit (Applied Biosystems) and Oligo dT primer (Invitrogen). Obtained cDNAs were subjected to qRT-PCR using TaqMan GAPDH forward [a] 5'-TCGCTCTCTGCTCCTCCTGTTC-3'
GAPDH reverse [a] 5'-CGCCCAATACGACCAAATCC-3' 18S rRNA forward [b] 5'-CGGCGACGACCCATTCGAAC -3' 18S rRNA forward [b] 5'-GAATCGAACCCTGATTCCCCGTC -3'
[a] GAPDH is normally used as a control. [b] 18S rRNA is used as a control for GAPDH expression.
